General Info

Mina Nikanjam, MD, PhD, is a medical oncologist who specializes in treating melanoma and other skin cancers, as well as rare tumors. She also specializes in experimental therapeutics and early phase clinical trials with the goal of providing patients with state of the art treatments. Many of these novel therapies are designed to be more effective with less toxicity and targeted for individualized therapy.As an assistant professor in the Department of Medicine, Dr. Nikanjam instructs medical students, residents and fellows at the UC San Diego School of Medicine. Her research interests include using computer modeling and simulation to determine how drug dose and blood levels relate to response to therapy (clinical pharmacology), and precision medicine / personalized therapies. She has co-authored numerous articles and her work has been published in journals such as The Oncologist, International Journal of Cancer, OncoImmunology, and Oncotarget, among others.Dr. Nikanjam completed a fellowship in hematology-oncology at UCLA David Geffen School of Medicine and a residency in internal medicine at Kaiser Permanente Santa Clara. She earned her medical degree from UC San Diego School of Medicine and her doctoral degree from the UC Berkeley - UCSF Bioengineering Graduate Program. Dr. Nikanjam is board certified in internal medicine.She is a member of the American Society of Clinical Oncology and the American Society of Hematology.Outside of work, Dr. Nikanjam enjoys running.UC San Diego Health LinksFor more information, see https://health.ucsd.edu/specialties/cancer/programs/skin/Pages/default.aspx and https://health.ucsd.edu/specialties/cancer/Pages/default.aspx.